Institutional investors purchased a net $5.1 million shares of IRWD during the quarter ended December 2015. This may signal that the smart money is gaining interest in this company as the 110.08% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
POINT72 ASSET MANAGEMENT LP Bought 5.0 Million shares of Ironwood Pharmaceuticals ...